osimertinib
astrazeneca
['osimertinib']
adjuvant osimertinib demostrated a statistically and cinically significant improvement in os vs placebo in the primary population of stage li-llla disease. #asco2023 #asco23 
Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla. Cancer treatment must be personalized to the individual needs of the patient.